4/A//SEC Filing
Sinnreich Matthew Phillip 4/A
Accession 0001829126-22-018721
CIK 0001557376other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 5:01 PM ET
Size
5.4 KB
Accession
0001829126-22-018721
Insider Transaction Report
Form 4/AAmended
Sinnreich Matthew Phillip
DirectorPresident and Acting CEO
Transactions
- Other
Common Stock, $0.001 par value
2022-10-31−6,976,000→ 0 total(indirect: See Footnote)
Footnotes (1)
- [F1]On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares.
Documents
Issuer
Organicell Regenerative Medicine, Inc.
CIK 0001557376
Entity typeother
Related Parties
1- filerCIK 0001939708
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 5:01 PM ET
- Size
- 5.4 KB